There are two things. I don't think the letter hurts. I wouldn't necessarily rule it as powerful, because it's happening already, so I don't think it adds any weight of persuasion to something that's already been convinced.... The minister has already announced money. She's convening this urgent conference in the summer of the top officials, doctors, scientists, and researchers in the country.
I understand that the provincial health ministries are being asked for submissions of who their top people are. The understanding I got from Monday night was that the minister is feeling that it shouldn't be restricted to politicians, because politicians obviously aren't the ones with the most medical expertise to be building this case of evidence as to why this treatment should be available. Obviously that makes a lot of sense. If the provinces require further evidence, then obviously it needs to be the top researchers who build that case.
Another interesting thing that I thought came out of Tuesday was that Alain Beaudet said that the money available with CIHR is not restricted. It doesn't exclude a treatment arm. He said very clearly that clinical research involving treatment was something they were looking for.
I think what we need to do urgently is to make sure those applications go in. I understand there is something coming from Sunnybrook in conjunction with RVH, which would hopefully allow Dr. McDonald to do clinical research that involves treatment. I know that we were all impressed by his testimony. But it's the dearth of applications that's the greatest challenge right now.
The MS Society has said that they requested an additional $10 million to CIHR and Dr. Beaudet and the health minister said it shouldn't be restricted to only $10 million. If we have $12 million in excellent applications for clinical research, why not fund $12 million?
But that said, if you only have $6 million in research, why take away $4 million that could be going to autism or Parkinson's? That's why the figure hasn't been set in stone: because it's based on applications.
The biggest worry right now is that we're not getting those applications in. Maybe as parliamentarians we can encourage people we know in the research community to put in those applications. That's how we could help people the most in the coming months.
Adding a letter doesn't hurt. Does it help? It's already helping. I certainly don't think it causes any harm, but I wouldn't put out alarm bells by viewing that as absolutely necessary.
I think what we've learned in this process is that every province has a health advisory technology committee. They have their college of physicians and surgeons. They're the ones who are saying they're requiring evidence.
For example, in my own local paper today, Aileen Carroll actually wrote a column praising Dr. Bennett and Dr. Duncan, by the way—you'd be interested to know—for raising this in the House of Commons. She said that she has been in conversation with the health minister, and the health minister said this will not be authorized in Ontario—this is in The Barrie Examiner today—because there's not adequate evidence.
Well, we need to give every health minister in the country adequate evidence. The only way you're going to get that is through encouraging applications for clinical research that has a treatment arm and that's what the CIHR is looking for.